NEFA (drug)
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Edgar181 (talk | contribs) at 14:57, 8 January 2019 (isomeric SMILES). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
 | |
| Identifiers | |
|---|---|
| |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H19N |
| Molar mass | 213.324 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
NEFA is a moderate affinity NMDA antagonist (IC50 = 0.51 μM). It is a structural analog of phencyclidine.[1] It was first synthesized by a team at Parke-Davis in the late 1950s.[2]
References
- ^ Dilmore JG, Johnson JW (1998). "Open channel block and alteration of N-methyl-D-aspartic acid receptor gating by an analog of phencyclidine". Biophysical Journal. 75 (4): 1801–16. doi:10.1016/S0006-3495(98)77622-2. PMC 1299852. PMID 9746522.
- ^ GB Patent 893920 - Polycyclic amino compounds and methods for their production
| AMPARTooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
|
|---|---|
| KARTooltip Kainate receptor |
|
| NMDARTooltip N-Methyl-D-aspartate receptor |
|
 | This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Infobox drug articles with non-default infobox title
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- All stub articles